3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Dermatologic
1
Conditions
Neoplasms
17
Carcinoma, Non-Small-Cell Lung
11
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Breast Neoplasms
3
Head and Neck Neoplasms
2
Glioblastoma
2
Thrombocytosis
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Pleural Diseases
1
Oligodendroglioma
1
Neoplasms, Squamous Cell
1
Neoplasms by Site
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Meningioma
1
Interventions
pembrolizumab
6
Cisplatin
6
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiotherapy
3
Radiation
3
Nivolumab
3
Fluorouracil
3
Biopsy
3
Surveys and Questionnaires
2
Radiosurgery
2
Paclitaxel
2
Chemoradiotherapy
2
Cetuximab
2
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
2
zimberelimab
1
toripalimab
1
temsirolimus
1
peposertib
1
nabiximols
1
motexafin gadolinium
1
mogamulizumab
1
ipatasertib
1
dl1520
1
camrelizumab
1
brodalumab
1
belinostat
1
apatinib
1
advexin
1
Valproic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Mouth Neoplasms
×
Afatinib
×
Clear all
NCT06897735
2026-06-03
EDDIS-a1
Petrov, Andrey
Phase 1
Terminated
4 enrolled